

  • VBP & High-value Economics

  • Clinical Evaluation & Access

  • Biocompatibility & Toxicology

  • Advanced Dressings

    
    • Collagen/Alginate Dressings

    • NPWT Systems

    • Ag-Silicone Foam Dressings

  • Medical Catheters

    
    • Antimicrobial Catheters

    • IV Cannulas

    • Hydrophilic Microcatheter

  • Surgical Staplers

    
    • Circular Staplers

    • Powered Surgical Staplers

    • Endoscopic Linear Staplers

  • Cardiovascular Devices

    
    • Nitinol Occluders

    • TAVR/TAVI Valves

    • Drug-eluting Stents/Balloons

  • Orthopedic Implants

    
    • Trauma Nails & Plates

    • Bioceramic Fillers

    • 3D Printed Ti Implants


Location: Home > Cardiovascular Devices

Cardiovascular Devices

Cardiovascular Devices overview covering key technologies, applications, suppliers, and global industry trends.
  • Drug Eluting Stents: Key Clinical Endpoints to Compare
    Author:Interventional Cardiology Architect
    Drug Eluting Stents: Key Clinical Endpoints to Compare
    Drug eluting stents comparison starts with the right clinical endpoints. Learn how to assess safety, efficacy, durability, and procurement value for smarter DES decisions.
    May 17, 2026
  • TAVR Valves: Clinical Access Trends and Selection Signals for 2026
    Author:Interventional Cardiology Architect
    TAVR Valves: Clinical Access Trends and Selection Signals for 2026
    TAVR valves in 2026: explore clinical access trends, physician selection signals, and sourcing pressures shaping market advantage, premium positioning, and smarter procurement decisions.
    May 16, 2026
  • Drug Eluting Stents: Cost vs Patency in Value-Based Purchasing
    Author:Interventional Cardiology Architect
    Drug Eluting Stents: Cost vs Patency in Value-Based Purchasing
    Drug eluting stents cost more upfront, but do they deliver better long-term value? Explore patency, reintervention risk, and evidence to make smarter purchasing decisions.
    May 16, 2026
  • Cardiovascular Device Development Bottlenecks Before Submission
    Author:Interventional Cardiology Architect
    Cardiovascular Device Development Bottlenecks Before Submission
    Cardiovascular device development often stalls before submission. Explore key bottlenecks in evidence, testing, clinical strategy, and regulatory alignment to reduce delays and improve approval confidence.
    May 12, 2026
  • <Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next>

Weekly Insights

Stay ahead with our curated technology reports delivered every Monday.

Subscribe Now

Related Industries

  • Can a single approval cover life science product sales worldwide?
    Selling a life science product worldwide? Learn why one approval is not enough and how to navigate local regulations, reuse evidence, and build a smarter global launch plan.
  • When is sensitization testing needed for medical device biocompatibility?
    Medical device biocompatibility sensitization testing: discover when new studies are needed, how ISO 10993 applies, and when existing evidence can justify avoiding additional tests.
  • How is biocompatibility tested for implantable polymer biomaterials?
    Implantable biomaterials polymers: explore how ISO 10993 testing, chemical analysis, and tissue response studies assess biological safety. Learn what matters for your implant.

IMCS

IMCS is a global intelligence portal focusing on implants, interventional devices, minimally invasive consumables and advanced regenerative materials.

Industries

  • Orthopedic Implants

  • Cardiovascular Devices

  • Surgical Staplers

  • Medical Catheters

  • Advanced Dressings

  • Biocompatibility & Toxicology

  • Clinical Evaluation & Access

  • VBP & High-value Economics

Legal

  • Resources

  • Contact us

  • About

Message

submit
Copyright © Global Implant & Medical Consumables Systems

Site Index

